Literature DB >> 2036334

Acute hemodynamic effects of molsidomine in patients with ischemic cardiomyopathy.

D G Caralis, Z Kyriakides, C Ioakimides.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2036334     DOI： 10.1007/bf03029812

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  5 in total

1.  Effects of molsidomine on left ventricular dimensions and cardiac function in patients with chronic heart failure.

Authors:  G M Berkenboom; J C Sobolski; P P Vandermoten; E E Stoupel; S G Degre
Journal:  Am Heart J       Date:  1985-03       Impact factor: 4.749

2.  Preload or afterload reduction: which is more beneficial for patients with ischemic heart disease?

Authors:  D G Caralis; Z Kyriakides
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

3.  Long-term clinical and hemodynamic results of molsidomine treatment in patients with refractory heart failure.

Authors:  J Acar; A Kulas; B Escudier
Journal:  Am Heart J       Date:  1985-03       Impact factor: 4.749

4.  [Pharmacological basis of therapy with molsidomine].

Authors:  E Bassenge
Journal:  Herz       Date:  1982-10       Impact factor: 1.443

5.  Hemodynamic effects of molsidomine vasodilatory therapy in acute myocardial infarction.

Authors:  M Aptecar; C A Otero y Garzon; A Vasquez; S Varini; L Collia; A Esteguy; S Caruso
Journal:  Am Heart J       Date:  1981-04       Impact factor: 4.749
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.